Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study - Detke, Holland C; Goadsby, Peter J; Wang, Shufang; Friedman, Deborah I; Selzler, Katherine J; Aurora, Sheena K (Neurology, 2018)
Keywords: Adult; Antibodies, Monoclonal - therapeutic use; Antibodies, Monoclonal, Humanized - therapeutic use; Chronic Disease - prevention & control; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders - drug therapy; Treatment Outcome